65 related articles for article (PubMed ID: 285048)
1. A retrospective study of patients with chronic myeloid leukemia diagnosed and treated at the Chaim Sheba Medical Center during the years 1966-76.
Inbal A; Modan M; Many A
Isr J Med Sci; 1978 Dec; 14(12):1259-64. PubMed ID: 285048
[TBL] [Abstract][Full Text] [Related]
2. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
3. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
Larrain C; Cruz A; Codoceo V
Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
[No Abstract] [Full Text] [Related]
4. Immunotherapy for chronic myelogenous leukemia: survival not affected by treatment in the stable phase.
Baker MA; Taub RN; Carter WH; Davidson M; Sutton DM; Kutas G; Berger S; Watt HJ
Cancer Res; 1984 Jan; 44(1):383-5. PubMed ID: 6360347
[TBL] [Abstract][Full Text] [Related]
5. [Parameters significant for the prognosis of chronic myeloid leukemia in the chronic phase].
Maras J; Ribicić I; Maras-Simunić M; Skare L
Acta Med Iugosl; 1990; 44(4):389-97. PubMed ID: 2091442
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective study.
Behringer B; Pitako JA; Kunzmann R; Schmoor C; Behringer D; Mertelsmann R; Lübbert M
Ann Hematol; 2003 Jul; 82(7):381-9. PubMed ID: 12756497
[TBL] [Abstract][Full Text] [Related]
7. [Survival of 29 cases of chronic myeloid leukemia treated by myleran].
Petitclerc C; Barry A
Union Med Can; 1976 Feb; 105(2):210-6. PubMed ID: 1069396
[No Abstract] [Full Text] [Related]
8. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
[TBL] [Abstract][Full Text] [Related]
9. The long-term results and survival in the treatment of chronic granulocytic leukaemia with Myleran.
Chrobák L; Radochová D; Chrobáková H
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969; 12(5):565-70. PubMed ID: 5267593
[No Abstract] [Full Text] [Related]
10. Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan.
Nielsen I; Hasselbalch HC
Am J Hematol; 2003 Sep; 74(1):26-31. PubMed ID: 12949887
[TBL] [Abstract][Full Text] [Related]
11. Estimation of chronic phase duration in Ph-positive chronic myelocytic leukemia treated with busulfan: statistical analysis on Japanese patients.
Hashimoto T; Ohtaki M; Ueoka H; Munaka M; Kuramoto A; Kamada N
Int J Hematol; 1994 Jul; 60(1):59-69. PubMed ID: 7919239
[TBL] [Abstract][Full Text] [Related]
12. Chromosome changes in patients treated with "Myleran".
Krajincanić B; Lazarov A; Zunić Z; Radojicić B
Strahlentherapie; 1976 May; 151(5):459-62. PubMed ID: 1064182
[TBL] [Abstract][Full Text] [Related]
13. [Etiology of maxillofacial trauma--a 10-year survey at the Chaim Sheba Medical Center, Tel-Hashomer].
Yoffe T; Shohat I; Shoshani Y; Taicher S
Harefuah; 2008 Mar; 147(3):192-196, 280. PubMed ID: 18488856
[TBL] [Abstract][Full Text] [Related]
14. [Varying course of pancytopenia after busulfan treatment of chronic myelocytic leukemia (CML)].
Krug K; Stenzel L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):181-7. PubMed ID: 79522
[TBL] [Abstract][Full Text] [Related]
15. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
16. [Interferon-alpha in the treatment of patients with chronic myeloid leukemia].
Faber E; Jarosová M; Divoký V; Luhový M; Komenda S; Sulovská I; Hubácek J; Slezák P; Papajik T; Raida L; Heczko M; Indrák K
Vnitr Lek; 1997 Jan; 43(1):13-7. PubMed ID: 9221559
[TBL] [Abstract][Full Text] [Related]
17. Busulfan lung.
Pearl M
Am J Dis Child; 1977 Jun; 131(6):650-2. PubMed ID: 266839
[TBL] [Abstract][Full Text] [Related]
18. Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia.
Bolin RW; Robinson WA; Sutherland J; Hamman RF
Cancer; 1982 Nov; 50(9):1683-6. PubMed ID: 6956430
[TBL] [Abstract][Full Text] [Related]
19. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL
J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA
Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
